companies / manasai-co
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 24,600,00024.6M | ○ |
|---|---|---|
| founded | 2024 | |
| hq | San Francisco, USA | |
| industry | unknown | |
| stage | seed |
Manas AI builds an AI platform that accelerates pharmaceutical drug discovery from target identification through clinical trials. It serves biopharma companies and research organizations aiming to cut the time and cost of new medicines. Its neuro-symbolic AI codifies first-principles rules from chemistry, physics, and biology.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-27 | seed | 24,600,00024.6M | null | ○ |
| investor | src |
|---|---|
| Greylock | ○ |
Vercel, Next.js, React, Webpack
| fact | status | src |
|---|---|---|
| Seed, $24.6M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-27latest_round: seed, $24.6M, 2025-01-27, lead: greylock → seed, $24.6M, 2025-01-27, lead: null, ○ 2026-05-05 | latest_round | seed, $24.6M, 2025-01-27, lead: greylock → seed, $24.6M, 2025-01-27, lead: null | ○ 2026-05-05 |
Records begin 2026-09-24. all_changes